Baseimmune
The company develops active immunotherapies by combining computational design with protein engineering to create bespoke antigens. These antigens are designed to address the complexities of chronic diseases where traditional vaccine approaches have failed. The platform aims to improve patient outcomes through the development of targeted treatments for chronic conditions.
Biotech
Healthcare
Immunotherapy
Funding summary
- Total raised
- €4.9M
- Funding rounds
- 2
Investors in Baseimmune
Investors on record for Baseimmune. Click any investor to view their CAPLINK profile and funding criteria.
Fundraising for a startup like Baseimmune?
Explore CAPLINK's investor database of thousands of active VCs and angels.
Browse investors